Search clinical trials for: Olaparib Oral Product

Total 11015 results

Henry Ford Health System
Allergan

Completed

The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects

Pigmentation

United States
Liquid I.V.
University of Memphis

Not yet recruiting

Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers

Tolerance
Mondelēz International, Inc.
University of Sydney

Completed

Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products

Metabolic Disorder

Australia
Pierre Fabre Medicament

Completed

Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia

Drug-induced Xerostomia

Germany
Pierre Fabre Dermo Cosmetique

Completed

Assessment of a Cosmetic Product Effect on the Host/Microorganism Relationship in Acneic Subjects

Acne

France
GlaxoSmithKline

Completed

To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT)

Skin Care

Brazil
Abbott Nutrition

Completed

Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
The Cleveland Clinic
RTI International

Completed

Pomalidomide for the Treatment of Bleeding in HHT (PATH-HHT)

Telangiectasia, Hereditary Hemorrhagic

United States
Universidad Católica San Antonio de Murcia

Completed

Efficacy of Different Types of Milk in Improving Sleep Quality in Subjects With Sleep Problems (Milca) (Milca)

Poor Quality Sleep

Spain
Danone Research

Completed

Effect of a Fermented Milk Product With Probiotics Alone or in Combination With Fibers on Constipation Symptoms

Healthy | Constipation

Ireland
AstraZeneca

Completed

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity

United States, Canada
AstraZeneca

Completed

Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status

Colorectal Cancer

United States
John Flickinger

Active, not recruiting

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

Glioblastoma

United States
National Liver Institute, Egypt
Pharco Pharmaceuticals

Unknown

Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients

Pharmacological Action

Egypt
Nutricia Research
INQUIS Clinical Research Ltd.

Completed

Assessment of the Glycemic Responses to Nutritional Products (GLIN#1)

Glycemic Response

Canada
Chong Kun Dang Pharmaceutical

Not yet recruiting

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

Benign Prostate Hypertrophy(BPH)

Korea, Republic of
Aventure AB
Berry Lab AB

Completed

Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function (SCANBerry)

Age-related Cognitive Decline

Sweden
Nantes University Hospital

Unknown

Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM) (CD lam)

Acute Myelogenous Leukemia

France
Harokopio University
National and Kapodistrian University of Athens

Completed

Cereal-based Products Fortified With Legumes and Effects on Glycemic Control and Appetite Regulation

Appetite

Greece
King's College London

Recruiting

Micronutrient Bioavailability From Wheat

Healthy

United Kingdom
Aventure AB

Completed

Evaluation of Postprandial Glycaemia in a Healthy Population After Intake of Milk and Oat Based Products

Healthy

Sweden
Shenzhen Precision Health Food Technology Co. Ltd...

Active, not recruiting

The Efficacy on Overweight With Oral Supplemenation of Probiotics and Prebiotics

Overweight

China
Coloplast A/S

Completed

Investigation of Two Newly Developed 2-piece Convex Baseplates in Subjects With Ileostomy

Stoma - Ileostomy

Denmark
Brown University
Taiho Oncology, Inc.

Recruiting

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Soft Tissue Sarcoma | Advanced Breast Cancer | SCLC | Bladder Cancer | Endometrial Cancer | Treatment-Refractory Solid Tumors | Retinoblastoma Deficiency

United States
AstraZeneca

No longer available

Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

PSR Ovarian Cancer With a BRCA Mutation

Japan
Universidad de Murcia

Completed

Evaluation of the Beneficial Health Effects of an Additive-free Meat Product in Healthy Subjects (HIPOCARNE)

Inflammation | Oxidative Stress | Food Toxicity

Spain
Danone Research

Completed

Evaluation of Dose-effect of a New Fermented Food in Healthy Adults

Healthy

Germany
AstraZeneca
Merck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.

Completed

Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer (CONCERTO)

Recurrent Platinum Resistant Ovarian Cancer

United States
AstraZeneca

Active, not recruiting

Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Breast | Prostate | Ovarian | Pancreatic | Advanced Tumours

Sweden, Spain, Israel, Australia, Germany
Roquette Canada, LTD.

Completed

Investigation of the Efficacy and Safety of Three Test Products and Comparator on Muscular Performance After the Initiation of a Resistance Training Program

Muscle Strength

Canada
Pharmtechnology LLC
Altasciences Company, Inc.

Completed

The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions

Bioequivalence

Canada
University of Michigan
DMG Dental Material Gesellschaft mbH

Completed

Radiographic Progression of Infiltrated Caries Lesions In-vivo (ICON)

Dental Caries

United States
AB Biotics, SA

Completed

Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners (AB-ULTRA)

Signs and Symptoms

Spain
Church & Dwight Company, Inc.
Essential Access Health

Completed

Synthetic Male Condom Slippage-Breakage Study

Sexually Transmitted Diseases | Contraceptive

United States
AstraZeneca

Active, not recruiting

To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.

Metastatic Triple Negative Breast Cancer

United States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
Sanofi

Completed

Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects

Rheumatoid Arthritis
National Cancer Institute, Naples

Recruiting

Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study (MITO 31)

BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Italy
National Cancer Institute (NCI)

Recruiting

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Lung Neoplasms | Small Cell Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Urothelial Cancer

United States
Sheba Medical Center

Completed

Efficacy and Safety of PARPi to Treat Pancreatic Cancer (10)

Pancreatic Cancer

Israel
AstraZeneca
Parexel

Approved for marketing

Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Ovarian Cancer

United States
Abbott Nutrition

Completed

Comparison of Nutritional Products for People With Type 2 Diabetes

Diabetes Mellitus, Type 2

Spain
Tianjin Medical University Cancer Institute and...

Recruiting

Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer

China
Erasmus Medical Center

Recruiting

Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors (PRRT-PARPi)

Neuroendocrine Tumors | Peptide Receptor Radionuclide Therapy

Netherlands
AstraZeneca

Completed

Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies

Cancer | Advanced Solid Malignancies

Japan
Istituti Ospitalieri di Cremona

Unknown

Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients

Breast Cancer | Triple Negative Breast Cancer
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; International Centre for Diarrhoeal Disease...

Completed

Protein Plus: Improving Infant Growth Through Diet and Enteric Health (JiVitA-6)

Stunting | Campylobacter Infections | Malnutrition; Protein | Enteric Pathogens

Bangladesh
Medstar Health Research Institute

Active, not recruiting

Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L (Magical)

Fibroid Uterus | Heavy Menstrual Bleeding

United States
Medicines Development for Global Health

Recruiting

Efficacy and Safety Study of Moxidectin in Adults With Scabies

Scabies

United States, Honduras
Grupo Español de Investigación en Neurooncología
Tilray; Medical Cannabis Bike Tour; Voices Against Brain Cancer

Recruiting

TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma (GEINOCANN)

Glioblastoma

Spain
Ain Shams University
Cairo University

Completed

Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy

Hepatitis C, Chronic | Hematologic Malignancy

Egypt

3

Subscribe